Annual Total Debt
$32.00 B
-$886.80 M-2.70%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual total debt is $32.00 billion, with the most recent change of -$886.80 million (-2.70%) on March 31, 2024.
- During the last 3 years, TAK annual total debt has fallen by -$10.02 billion (-23.84%).
- TAK annual total debt is now -38.30% below its all-time high of $51.87 billion, reached on March 31, 2019.
Performance
TAK Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$30.82 B
-$4.55 B-12.85%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly total debt is $30.82 billion, with the most recent change of -$4.55 billion (-12.85%) on December 1, 2024.
- Over the past year, TAK quarterly total debt has dropped by -$4.55 billion (-12.85%).
- TAK quarterly total debt is now -41.17% below its all-time high of $52.39 billion, reached on June 30, 2019.
Performance
TAK Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TAK Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.7% | -12.8% |
| 3 y3 years | -23.8% | -6.3% |
| 5 y5 years | -38.3% | -26.6% |
TAK Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.8% | at low | -18.6% | at low |
| 5 y | 5-year | -38.3% | at low | -35.7% | at low |
| alltime | all time | -38.3% | -100.0% | -41.2% | -100.0% |
Takeda Pharmaceutical Company Limited Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $30.82 B(-12.9%) |
| Sep 2024 | - | $35.37 B(+3.8%) |
| Jun 2024 | - | $34.06 B(+6.4%) |
| Mar 2024 | $32.00 B(-2.7%) | $32.00 B(-3.2%) |
| Dec 2023 | - | $33.07 B(+5.6%) |
| Sep 2023 | - | $31.32 B(-4.5%) |
| Jun 2023 | - | $32.78 B(-0.3%) |
| Mar 2023 | $32.89 B(-7.6%) | $32.89 B(+0.6%) |
| Dec 2022 | - | $32.70 B(-0.3%) |
| Sep 2022 | - | $32.79 B(-2.7%) |
| Jun 2022 | - | $33.69 B(-5.4%) |
| Mar 2022 | $35.60 B(-15.3%) | $35.60 B(-5.9%) |
| Dec 2021 | - | $37.84 B(+0.1%) |
| Sep 2021 | - | $37.80 B(-5.2%) |
| Jun 2021 | - | $39.86 B(-5.2%) |
| Mar 2021 | $42.02 B(-10.8%) | $42.02 B(-8.8%) |
| Dec 2020 | - | $46.07 B(-0.8%) |
| Sep 2020 | - | $46.44 B(-1.5%) |
| Jun 2020 | - | $47.17 B(+0.1%) |
| Mar 2020 | $47.13 B(-9.1%) | $47.13 B(-1.7%) |
| Dec 2019 | - | $47.95 B(+3.0%) |
| Sep 2019 | - | $46.54 B(-11.2%) |
| Jun 2019 | - | $52.39 B(+1.0%) |
| Mar 2019 | $51.87 B(+459.2%) | $51.87 B(+124.6%) |
| Dec 2018 | - | $23.10 B(+162.4%) |
| Sep 2018 | - | $8.80 B(-2.2%) |
| Jun 2018 | - | $9.00 B(-2.9%) |
| Mar 2018 | $9.28 B(-9.4%) | $9.28 B(-8.2%) |
| Dec 2017 | - | $10.10 B(-0.1%) |
| Sep 2017 | - | $10.11 B(-1.1%) |
| Jun 2017 | - | $10.22 B(-0.2%) |
| Mar 2017 | $10.24 B(+49.8%) | $10.24 B(+22.0%) |
| Dec 2016 | - | $8.39 B(-10.7%) |
| Sep 2016 | - | $9.40 B(+1.2%) |
| Jun 2016 | - | $9.28 B(+35.8%) |
| Mar 2016 | $6.83 B | $6.83 B(+12.8%) |
| Dec 2015 | - | $6.06 B(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $6.08 B(+1.8%) |
| Jun 2015 | - | $5.98 B(-1.7%) |
| Mar 2015 | $6.08 B(-27.3%) | $6.08 B(-20.5%) |
| Dec 2014 | - | $7.64 B(-5.0%) |
| Sep 2014 | - | $8.04 B(-4.7%) |
| Jun 2014 | - | $8.44 B(+1.0%) |
| Mar 2014 | $8.36 B(+34.6%) | $8.36 B(+10.8%) |
| Dec 2013 | - | $7.54 B(-6.7%) |
| Sep 2013 | - | $8.09 B(+47.1%) |
| Jun 2013 | - | $5.50 B(-11.4%) |
| Mar 2013 | $6.21 B(-5.8%) | $6.21 B(-1.5%) |
| Dec 2012 | - | $6.30 B(-9.7%) |
| Sep 2012 | - | $6.98 B(+2.0%) |
| Jun 2012 | - | $6.84 B(+3.8%) |
| Mar 2012 | $6.59 B(+2572.3%) | $6.59 B(-5.4%) |
| Dec 2011 | - | $6.97 B(-6.4%) |
| Sep 2011 | - | $7.44 B(>+9900.0%) |
| Jun 2011 | - | $15.74 M(-93.6%) |
| Mar 2011 | $246.59 M(+22.7%) | $246.59 M(+527.8%) |
| Dec 2010 | - | $39.28 M(+10.0%) |
| Sep 2010 | - | $35.69 M(+3.3%) |
| Jun 2010 | - | $34.56 M(-82.8%) |
| Mar 2010 | $201.01 M(+0.7%) | $201.01 M(+472.7%) |
| Dec 2009 | - | $35.10 M(+1.8%) |
| Sep 2009 | - | $34.48 M(>+9900.0%) |
| Jun 2009 | - | $0.00(-100.0%) |
| Mar 2009 | $199.62 M(+493.3%) | $199.62 M(+389.7%) |
| Dec 2008 | - | $40.76 M(>+9900.0%) |
| Sep 2008 | - | $0.00 |
| Mar 2008 | $33.64 M(-65.8%) | - |
| Mar 2007 | $98.51 M(-7.8%) | - |
| Mar 2006 | $106.85 M(-38.1%) | - |
| Mar 2005 | $172.62 M(+22.9%) | - |
| Mar 2004 | $140.47 M(+32.0%) | - |
| Mar 2003 | $106.39 M(-9.5%) | - |
| Mar 2002 | $117.62 M(-7.9%) | - |
| Mar 2001 | $127.66 M(>+9900.0%) | - |
| Mar 2000 | $0.00 | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total debt?
- What is the all time high annual total debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total debt year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total debt?
- What is the all time high quarterly total debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total debt year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total debt?
The current annual total debt of TAK is $32.00 B
What is the all time high annual total debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total debt is $51.87 B
What is Takeda Pharmaceutical Company Limited annual total debt year-on-year change?
Over the past year, TAK annual total debt has changed by -$886.80 M (-2.70%)
What is Takeda Pharmaceutical Company Limited quarterly total debt?
The current quarterly total debt of TAK is $30.82 B
What is the all time high quarterly total debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total debt is $52.39 B
What is Takeda Pharmaceutical Company Limited quarterly total debt year-on-year change?
Over the past year, TAK quarterly total debt has changed by -$4.55 B (-12.85%)